pharmaphorum
APRIL 26, 2021
Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.
Pharma Marketing Network
APRIL 28, 2021
Introducing the recipient of the 2020-21 HBA Honorable Mentor Award, Dr. Rod MacKenzie , Chief Development Officer and EVP, Pfizer and the recipient of the 2020-21 HBA STAR Award, Susan Torroella , Chief Operating Officer, ArmadaHealth. What is the Honorable Mentor Award? The Honorable Mentor award recognizes a man who demonstrates a long-term commitment to advancing women in the workforce, is dedicated to developing, mentoring and promoting women in the industry, and is supportive of the overal
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
APRIL 29, 2021
Apixaban (Eliquis®) and warfarin are two popular prescription-only drugs classified as anticoagulants, commonly known as blood thinners. Warfarin has been used as an anticoagulant for a very long time. However, in recent years warfarin’s popularity decreased in place of newer anticoagulants such as apixaban, as reflected by prescribing statistics.
Outsourcing Pharma
APRIL 26, 2021
Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
APRIL 26, 2021
The neuroQWERTY technology can analyse people’s typing for signs of motor conditions like Parkinson’s disease – and now the team behind it is looking to expand into the notoriously-difficult area of dementia. Teresa Arroyo-Gallego tells us about the science behind the technology and how the team hopes to reshape cognitive screening. . While many disease areas are increasingly embracing digital forms of diagnosis and treatment, neurology is still largely stuck in an “analogue era”, according to n
Pharma Marketing Network
APRIL 28, 2021
With our growing audience of pharma and healthcare professionals, the Pharma Marketing Network (PMN) leverages its experience in helping drive registrations for top-rated events and conferences that attracts diverse populations at scale. Let’s work together to identify the unique needs of your event and produce maximum engagement. Fill out the form below to learn all the perks of partnering with PMN to make your next event the most successful it can be.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
APRIL 28, 2021
The combination of companies brings together ERTâs clinical endpoint data capabilities and Bioclinicaâs imaging, eClinical and drug-safety solutions.
pharmaphorum
APRIL 30, 2021
Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population. However due to the rarity of incidences from vaccination, myGP explores the most common causes of blood clots and how we can prevent them. Over 11 million doses of COVID-19 vaccines have been given across the UK, with blood clotting observed in a small sample of patients.
Pharma Marketing Network
APRIL 30, 2021
Clinical trials may be one of the very last bastions of a non-customer-focused approach within the pharmaceutical industry. Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.
Pharma Times
APRIL 27, 2021
The Christie NHS Foundation Trust will offer the breast cancer treatment Phesgo to patients in their own homes
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
APRIL 26, 2021
The chairman, president and CEO of Thermo Fisher says the acquisition stands to benefit clinical trial and drug development clients in a long list of ways.
pharmaphorum
APRIL 28, 2021
Today, most drug discovery programmes begin with the identification and validation of disease modifying biological targets. The primary way to uncover these targets is through searching and reviewing published scientific literature. Eric Gilbert explores how data science techniques like text mining are speeding up research into areas such as pancreatic cancer.
Pharma Marketing Network
APRIL 29, 2021
[link]. The post DarshanTalks: How Are Your Candidates #jobhacking?</br>– April 29, 2021 appeared first on Pharma Marketing Network.
Pharma Times
APRIL 29, 2021
ViroCell Biologics will meet the growing demand for viral vectors in clinical trials
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
pharmaphorum
APRIL 27, 2021
Cognoa has filed for FDA approval of a digital device that could be used to diagnose autism, which the company argues could redefine care standards. . Autism can be difficult to diagnose as there are no medical markers to show its presence – instead doctors look at the child’s developmental history and behaviour to make a diagnosis. Cognoa hopes to change this with an efficient and accurate approach that could allow diagnosis in primary care that won’t require a lengthy referral to a specialist.
Pharma Mirror
APRIL 28, 2021
Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.
Pharma Times
APRIL 30, 2021
Report notes a ‘modest’ impact on pre-pandemic drivers of medicine use and spending from COVID-19
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
APRIL 29, 2021
A leader from the CRO talks about increased use of electronic patient-reported outcomes in research, challenges of adoption, and how ePRO benefits trials.
pharmaphorum
APRIL 27, 2021
Protracted diagnostic odysseys don’t only block access to rare disease treatments, they also leave people facing emotional turmoil all alone. Growing up in Glasgow, Linsey Brady “felt like a freak” and did everything she could to hide what she was told was a vascular deformation on her leg from the rest of the world. She was in her late 20s when, after years of struggling with her mental health and self-medicating with alcohol, she was finally diagnosed with Klippel Trenaunay Syndrome (KTS).
Pharma Mirror
APRIL 28, 2021
AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies, including its lead program in Friedreich’s Ataxia (FA).
Pharma Times
APRIL 30, 2021
Extra doses will be used for UK's planned booster vaccination programme in autumn
Outsourcing Pharma
APRIL 29, 2021
New preclinical research, published in Nature, suggests a new avenue for Alzheimerâs disease (AD) treatment, through restoring lymphatic flow in the brain.
pharmaphorum
APRIL 30, 2021
Indivior has paid out $300 million to resolve civil claims from US states after it was last year found guilty against criminal charges of improper marketing of the opioid addiction drug Suboxone. Last year, Indivior reached a $600 million settlement plea deal to settle criminal fraud charges, after US authorities found the company’s conduct had results in improper use of state Medicaid funds.
Pharma Mirror
APRIL 28, 2021
Tokyo 27th April 2021: CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe. The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In fact, such has been the demand, CPhI Japan Connect – the event’s digital platform for international audiences – will remain open until the end of May.
Pharma Times
APRIL 26, 2021
Monoclonal antibody reduced lower respiratory tract infections due to RSV in healthy infants
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
pharmaphorum
APRIL 30, 2021
The NHS app could be used a kind of vaccine passport, according to UK government sources, although it is unclear how far the project has progressed. . NHS England’s app is connected to GP services in England and linked to personal health data and as such could be used to show a person’s vaccine status before travelling. People can already use the app to request repeat subscriptions, message their doctor and organise online consultations.
Pharma Marketing Network
APRIL 27, 2021
HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. Rod MacKenzie, PhD, is Chief Development Officer and Executive Vice President for Pfizer. Rod leads the Global Product Development organization, which is responsible for the clinical development and advancement of Pfizer’s pipeline of innovative medicines in inflammation and immunology, internal medicine, hospital, oncology and rare disease, as well as regulatory affairs in support of Pfizer’s R&D pipeline and portfolio of marketed therapies.
Pharma Mirror
APRIL 27, 2021
Scivita Medical Technology Co., Ltd. (“Scivita Medical”) announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment.
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
pharmaphorum
APRIL 29, 2021
Calliditas Therapeutics could have its first product on the market in the US this autumn, as the FDA has now started a priority review of Nefecon for rare disease primary IgA nephropathy (IgAN). . The Swedish biotech says the IUS regulator has set an action date of 15 September for its review of Nefecon, a novel formulation of the established corticosteroid drug budesonide that could become the first ever approved therapy for IgAN.
Pharma Marketing Network
APRIL 27, 2021
HBA STAR 2020-21, Susan Torroella. The 2020-2021 HBA STAR is Susan Torroella, President and CEO of ArmadaHealth, the leader in physician recommendation intelligence provided to employers through its QualityCare Connect? solution. For more than twenty years, Susan has been a dedicated HBA volunteer serving on the global board of directors, including as President of the Global Board in 2010.
Expert insights. Personalized for you.
122 
Let's personalize your content